| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 6290044
[patent_doc_number] => 20100158938
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-24
[patent_title] => 'Tetravalent Dengue Vaccines'
[patent_app_type] => utility
[patent_app_number] => 12/471962
[patent_app_country] => US
[patent_app_date] => 2009-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 32796
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0158/20100158938.pdf
[firstpage_image] =>[orig_patent_app_number] => 12471962
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/471962 | Tetravalent Dengue Vaccines | May 25, 2009 | Abandoned |
Array
(
[id] => 6588136
[patent_doc_number] => 20100291540
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-18
[patent_title] => 'CARBOHYDRATE BINDING MODULE AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/464788
[patent_app_country] => US
[patent_app_date] => 2009-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 4138
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0291/20100291540.pdf
[firstpage_image] =>[orig_patent_app_number] => 12464788
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/464788 | CARBOHYDRATE BINDING MODULE AND USE THEREOF | May 11, 2009 | Abandoned |
Array
(
[id] => 8834301
[patent_doc_number] => 08450056
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-05-28
[patent_title] => 'Arrayed imaging reflectometry (AIR) sensor chip comprising virus-like particles suitable for the detection of antiviral immune responses'
[patent_app_type] => utility
[patent_app_number] => 12/434298
[patent_app_country] => US
[patent_app_date] => 2009-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 9313
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 144
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12434298
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/434298 | Arrayed imaging reflectometry (AIR) sensor chip comprising virus-like particles suitable for the detection of antiviral immune responses | Apr 30, 2009 | Issued |
Array
(
[id] => 8920688
[patent_doc_number] => 08486619
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-07-16
[patent_title] => 'Arrayed imaging reflectometry (air) sensor chip comprising influenza hemagglutinin (HA) polypeptides suitable for the detection of antiviral immune responses'
[patent_app_type] => utility
[patent_app_number] => 12/434438
[patent_app_country] => US
[patent_app_date] => 2009-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 22
[patent_no_of_words] => 13956
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 142
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12434438
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/434438 | Arrayed imaging reflectometry (air) sensor chip comprising influenza hemagglutinin (HA) polypeptides suitable for the detection of antiviral immune responses | Apr 30, 2009 | Issued |
Array
(
[id] => 5936014
[patent_doc_number] => 20110212118
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-01
[patent_title] => 'TAT Protein for preventing or treating AIDS'
[patent_app_type] => utility
[patent_app_number] => 12/989165
[patent_app_country] => US
[patent_app_date] => 2009-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 14478
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0212/20110212118.pdf
[firstpage_image] =>[orig_patent_app_number] => 12989165
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/989165 | Modified Tat Oyi protein with enhanced immunogenicity | Apr 21, 2009 | Issued |
Array
(
[id] => 5936014
[patent_doc_number] => 20110212118
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-01
[patent_title] => 'TAT Protein for preventing or treating AIDS'
[patent_app_type] => utility
[patent_app_number] => 12/989165
[patent_app_country] => US
[patent_app_date] => 2009-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 14478
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0212/20110212118.pdf
[firstpage_image] =>[orig_patent_app_number] => 12989165
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/989165 | Modified Tat Oyi protein with enhanced immunogenicity | Apr 21, 2009 | Issued |
Array
(
[id] => 7487513
[patent_doc_number] => 20110236409
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-29
[patent_title] => 'OVERLAPPING PEPTIDES FROM VARIABLE ANTIGENS, T CELL POPULATIONS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/936370
[patent_app_country] => US
[patent_app_date] => 2009-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 12701
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0236/20110236409.pdf
[firstpage_image] =>[orig_patent_app_number] => 12936370
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/936370 | OVERLAPPING PEPTIDES FROM VARIABLE ANTIGENS, T CELL POPULATIONS AND USES THEREOF | Mar 29, 2009 | Abandoned |
Array
(
[id] => 6024305
[patent_doc_number] => 20110052631
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-03
[patent_title] => 'INDUCTION OF PROLIFERATION, EFFECTOR MOLECULE EXPRESSION, AND CYTOLYTIC CAPACITY OF HIV-SPECIFIC CD8+ T CELLS'
[patent_app_type] => utility
[patent_app_number] => 12/934522
[patent_app_country] => US
[patent_app_date] => 2009-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 15468
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0052/20110052631.pdf
[firstpage_image] =>[orig_patent_app_number] => 12934522
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/934522 | INDUCTION OF PROLIFERATION, EFFECTOR MOLECULE EXPRESSION, AND CYTOLYTIC CAPACITY OF HIV-SPECIFIC CD8+ T CELLS | Mar 24, 2009 | Abandoned |
Array
(
[id] => 8188356
[patent_doc_number] => 08182820
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-05-22
[patent_title] => 'Method for inducing cross-reactive immune responses to the human immunodeficiency virus (HIV) in a host by administering feline immunodeficiency virus (FIV) capsid (CA) or reverse transcriptase (RT) immunogens'
[patent_app_type] => utility
[patent_app_number] => 12/407730
[patent_app_country] => US
[patent_app_date] => 2009-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 42
[patent_no_of_words] => 14235
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/182/08182820.pdf
[firstpage_image] =>[orig_patent_app_number] => 12407730
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/407730 | Method for inducing cross-reactive immune responses to the human immunodeficiency virus (HIV) in a host by administering feline immunodeficiency virus (FIV) capsid (CA) or reverse transcriptase (RT) immunogens | Mar 18, 2009 | Issued |
Array
(
[id] => 5342395
[patent_doc_number] => 20090181045
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-16
[patent_title] => 'TAT-BASED VACCINE COMPOSITIONS AND METHODS OF MAKING AND USING SAME'
[patent_app_type] => utility
[patent_app_number] => 12/405086
[patent_app_country] => US
[patent_app_date] => 2009-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 9687
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0181/20090181045.pdf
[firstpage_image] =>[orig_patent_app_number] => 12405086
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/405086 | TAT-BASED VACCINE COMPOSITIONS AND METHODS OF MAKING AND USING SAME | Mar 15, 2009 | Abandoned |
Array
(
[id] => 6245989
[patent_doc_number] => 20100136098
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-03
[patent_title] => 'AVIAN INFLUENZA VACCINE'
[patent_app_type] => utility
[patent_app_number] => 12/400269
[patent_app_country] => US
[patent_app_date] => 2009-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11981
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0136/20100136098.pdf
[firstpage_image] =>[orig_patent_app_number] => 12400269
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/400269 | Immunogenic compositions comprising liposomes and an influenza PB2 CTL epitope obtained from the highly pathogenic H5N1 strain | Mar 8, 2009 | Issued |
Array
(
[id] => 7514933
[patent_doc_number] => 08039003
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-10-18
[patent_title] => 'Recombinant attenuated dengue viruses comprising a deletion in the 3′ untranslated region and additional attenuating mutations induced by chemical mutagenesis'
[patent_app_type] => utility
[patent_app_number] => 12/396376
[patent_app_country] => US
[patent_app_date] => 2009-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 14
[patent_no_of_words] => 53366
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/039/08039003.pdf
[firstpage_image] =>[orig_patent_app_number] => 12396376
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/396376 | Recombinant attenuated dengue viruses comprising a deletion in the 3′ untranslated region and additional attenuating mutations induced by chemical mutagenesis | Mar 1, 2009 | Issued |
Array
(
[id] => 5479628
[patent_doc_number] => 20090202585
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-13
[patent_title] => 'TAT-BASED TOLEROGEN COMPOSITIONS AND METHODS FOR MAKING AND USING SAME'
[patent_app_type] => utility
[patent_app_number] => 12/395975
[patent_app_country] => US
[patent_app_date] => 2009-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 11431
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0202/20090202585.pdf
[firstpage_image] =>[orig_patent_app_number] => 12395975
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/395975 | TAT-BASED TOLEROGEN COMPOSITIONS AND METHODS FOR MAKING AND USING SAME | Mar 1, 2009 | Abandoned |
Array
(
[id] => 6323672
[patent_doc_number] => 20100196992
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-05
[patent_title] => 'INTERGENIC REGIONS AS NOVEL SITES FOR INSERTION OF HIV DNA SEQUENCES IN THE GENOME OF MODIFIED VACCINIA VIRUS ANKARA'
[patent_app_type] => utility
[patent_app_number] => 12/393861
[patent_app_country] => US
[patent_app_date] => 2009-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 19149
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0196/20100196992.pdf
[firstpage_image] =>[orig_patent_app_number] => 12393861
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/393861 | Recombinant modified vaccinia virus ankara (MVA) comprising human immunodeficiency virus (HIV) genes inserted into one or more intergenic regions (IGRs) | Feb 25, 2009 | Issued |
Array
(
[id] => 6228925
[patent_doc_number] => 20100183663
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-22
[patent_title] => 'INTERGENIC REGIONS AS NOVEL SITES FOR INSERTION OF HIV DNA SEQUENCES IN THE GENOME OF MODIFIED VACCINIA VIRUS ANKARA'
[patent_app_type] => utility
[patent_app_number] => 12/393840
[patent_app_country] => US
[patent_app_date] => 2009-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 19124
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0183/20100183663.pdf
[firstpage_image] =>[orig_patent_app_number] => 12393840
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/393840 | Methods for inducing an immune response in a host comprising administering modified vaccinia virus ankara (MVA) recombinants comprising human immunodeficiency virus (HIV) genes inserted into one or more intergenic regions (IGRs) | Feb 25, 2009 | Issued |
Array
(
[id] => 6135216
[patent_doc_number] => 20110008889
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-13
[patent_title] => 'SERPIN DRUGS FOR TREATMENT OF HIV INFECTION AND METHOD OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/391669
[patent_app_country] => US
[patent_app_date] => 2009-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 16950
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0008/20110008889.pdf
[firstpage_image] =>[orig_patent_app_number] => 12391669
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/391669 | SERPIN DRUGS FOR TREATMENT OF HIV INFECTION AND METHOD OF USE THEREOF | Feb 23, 2009 | Abandoned |
Array
(
[id] => 5545897
[patent_doc_number] => 20090155774
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-18
[patent_title] => 'Fluorescence resonance energy transfer screening assay for the identification of HIV-1 envelope glycoprotein-medicated cell'
[patent_app_type] => utility
[patent_app_number] => 12/378572
[patent_app_country] => US
[patent_app_date] => 2009-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 15596
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0155/20090155774.pdf
[firstpage_image] =>[orig_patent_app_number] => 12378572
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/378572 | Fluorescence resonance energy transfer screening assay for the identification of HIV-1 envelope glycoprotein-medicated cell | Feb 16, 2009 | Abandoned |
Array
(
[id] => 6212908
[patent_doc_number] => 20110136208
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-09
[patent_title] => 'ANTIGEN-SPECIFIC REGULATORY T-CELL INDUCTION'
[patent_app_type] => utility
[patent_app_number] => 12/867703
[patent_app_country] => US
[patent_app_date] => 2009-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 11863
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0136/20110136208.pdf
[firstpage_image] =>[orig_patent_app_number] => 12867703
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/867703 | ANTIGEN-SPECIFIC REGULATORY T-CELL INDUCTION | Feb 12, 2009 | Abandoned |
Array
(
[id] => 5391217
[patent_doc_number] => 20090208530
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-20
[patent_title] => 'HIV polynucleotides and polypeptides derived from Botswana MJ4'
[patent_app_type] => utility
[patent_app_number] => 12/365215
[patent_app_country] => US
[patent_app_date] => 2009-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 24747
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0208/20090208530.pdf
[firstpage_image] =>[orig_patent_app_number] => 12365215
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/365215 | HIV polynucleotides and polypeptides derived from Botswana MJ4 | Feb 3, 2009 | Abandoned |
Array
(
[id] => 5397356
[patent_doc_number] => 20090317419
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-24
[patent_title] => 'Tetramers'
[patent_app_type] => utility
[patent_app_number] => 12/320709
[patent_app_country] => US
[patent_app_date] => 2009-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 18748
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0317/20090317419.pdf
[firstpage_image] =>[orig_patent_app_number] => 12320709
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/320709 | Tetramers | Feb 1, 2009 | Abandoned |